3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
2
Myocardial Reperfusion Injury
2
Cardiotoxicity
2
Vomiting
1
Uveal Melanoma
1
Thrombosis
1
Substance Withdrawal Syndrome
1
Retinal Diseases
1
Reperfusion Injury
1
Pain, Postoperative
1
Opioid-Related Disorders
1
Nausea
1
Melanoma
1
Macular Degeneration
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Choroid Diseases
1
Breast Neoplasms
1
Interventions
Bupivacaine
31
Ropivacaine
19
Dexmedetomidine
19
Saline Solution
18
Morphine
12
Ketamine
12
Sodium Chloride
10
Pregabalin
9
Lidocaine
9
Acetaminophen
9
Control Groups
7
Injections, Epidural
5
Gabapentin
4
Epinephrine
4
Dexamethasone
4
Anesthetics, Local
4
Anesthesia, General
4
Analgesia, Patient-Controlled
4
parecoxib
3
oxycodone-acetaminophen
3
Tea
3
Midazolam
3
Ketorolac
3
Fentanyl
3
Esketamine
3
Dental Occlusion
3
Vitamins
2
Tramadol
2
Surgical Procedures, Operative
2
Sufentanil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pain, Postoperative
×
salicylhydroxamic acid
×
Clear all
NCT04085237
2026-06-04
ESPB
McMaster University
Phase NA
Terminated
10 enrolled